Welcome to LookChem.com Sign In|Join Free

CAS

  • or

494799-19-8

Post Buying Request

494799-19-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

494799-19-8 Usage

Uses

Methyl 2-Bromo-3-cyclohexyl-6-indolecarboxylate is an indole derivatives as antiviral agents and their use in the treatment of hepatitis C virus infection.

Check Digit Verification of cas no

The CAS Registry Mumber 494799-19-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,4,7,9 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 494799-19:
(8*4)+(7*9)+(6*4)+(5*7)+(4*9)+(3*9)+(2*1)+(1*9)=228
228 % 10 = 8
So 494799-19-8 is a valid CAS Registry Number.
InChI:InChI=1/C16H18BrNO2/c1-20-16(19)11-7-8-12-13(9-11)18-15(17)14(12)10-5-3-2-4-6-10/h7-10,18H,2-6H2,1H3

494799-19-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 2-bromo-3-cyclohexyl-2-1H-indole-6-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:494799-19-8 SDS

494799-19-8Relevant articles and documents

HEPATITIS B CORE PROTEIN MODULATORS

-

, (2018/04/13)

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:

An efficient process for the large-scale synthesis of a 2,3,6-trisubstituted indole

Alorati, Anthony D.,Gibb, Andrew D.,Mullens, Peter R.,Stewart, Gavin W.

, p. 1947 - 1952 (2013/03/14)

The efficient synthesis of a key trisubstituted indole intermediate 1 is described. The synthetic route required the use of an aryl Grignard reagent which was not commercially available, and the large-scale formation of this fragment and the thermal evalu

CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS

-

Page/Page column 40-41, (2009/06/27)

The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 494799-19-8